Voluntary HIV Screening in the General Population in France

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07418385

Acronym

depistageVIH

Enrollment

1000

Registered

2026-02-18

Start date

2025-10-07

Completion date

2026-09-01

Last updated

2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus (HIV)

Keywords

HIV, voluntary screening

Brief summary

Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed. Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.

Detailed description

Objectives The main objective is to describe the voluntary HIV screening methods used by the general population in France.

Interventions

OTHERdata collections

data collections

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* 18 years of age or older * Male or female * Regardless of sexual orientation * Whether or not they have previously undergone voluntary HIV testing * Agreeing to participate in the study.

Exclusion criteria

* Minors * Refusing to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
The method(s) used for undergoing voluntary HIV testing questionnaire	Day 0	The method(s) used for undergoing voluntary HIV testing: medical prescription, Center for Free Information, Testing, and Diagnosis, medical laboratory, rapid diagnostic test (RDT), or self-test

Countries

France

Contacts

CONTACTGestonnairedu CURRS

currs@univ-reims.fr0326918822

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026